| MolName | (4Z)-4-[[4-(5-chloro-3,4-dihydropyrazol-2-yl)phenyl]methylidene]-1-(3-chlorophenyl)pyrazolidine-3,5-dione |
| MolecularFormula | C19H14N4O2Cl2 |
| Smiles | O=C(/C(/C1=O)=C/c(cc2)ccc2N(CC2)N=C2Cl)NN1c1cccc(Cl)c1 |
| InChI | InChI=1S/C19H14Cl2N4O2/c20-13-2-1-3-15(11-13)25-19(27)16(18(26)23-25)10-12-4-6-14(7-5-12)24-9-8-17(21)22-24/h1-7,10-11H,8-9H2,(H,23,26) |
| InChIK | DIPOQRMJQHHHPP-UHFFFAOYSA-N |
| TotalMolweight | 401.252 |
| Molweight | 401.252 |
| MonoisotopicMass | 400.04938 |
| CLogP | 2.3352 |
| CLogS | -3.7 |
| H Acceptors | 6 |
| H Donors | 1 |
| TotalSurfaceArea | 279.62 |
| Relative PSA | 0.20081 |
| PolarSurfaceArea | 65.01 |
| Druglikeness | 5.6467 |
| Mutagenic | high |
| Tumorigenic | low |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB; acyl-halogenide type |
| Shape Index | 0.59259 |
| Fragments | 1 |
| Non HAtoms | 27 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| Rotatable Bond | 3 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 2 |
| Symmetricatoms | 2 |
| StereoCon |
Click to Load Molecule:
1 - (4Z)-4-[[4-(5-chloro-3,4-dihydropyrazol-2-yl)phenyl]methylidene]-1-(3-chlorophenyl)pyrazolidine-3,5-dione | 2 - (4Z)-4-[[4-(5-chloro-3,4-dihydropyrazol-2-yl)phenyl]methylidene]-1-(3-chlorophenyl)pyrazolidine-3,5-dione